Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 3No longer available 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 3Plasma cell 1

Conditions

Leukemia 12Myelodysplastic Syndromes 11Leukemia, Myeloid, Acute 10Multiple Myeloma 8Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Non-Hodgkin 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, Follicular 3Hodgkin Disease 3Graft vs Host Disease 3Waldenstrom Macroglobulinemia 2Neoplasms, Plasma Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Hematologic Neoplasms 2Wilms Tumor 1Testicular Neoplasms 1Shwachman-Diamond Syndrome 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Philadelphia Chromosome 1Pathologic Complete Response 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Medulloblastoma 1

Interventions

Tacrolimus 37Methotrexate 27Cyclophosphamide 27Mycophenolic Acid 21fludarabine phosphate 19Busulfan 19Antilymphocyte Serum 19Cyclosporine 18Sirolimus 16Methylprednisolone 16fludarabine 15Peripheral Blood Stem Cell Transplantation 15Melphalan 14Filgrastim 13Radiotherapy 12Whole-Body Irradiation 8Granulocyte Colony-Stimulating Factor 8thymoglobulin 6Stem Cell Transplantation 6Rituximab 6Prednisone 6Pentostatin 6Hematopoietic Stem Cell Transplantation 5Etoposide 5ruxolitinib 4Thiotepa 4Flow Cytometry 4Cytarabine 4Cyclosporins 4Cord Blood Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Graft vs Host Disease × Bone Marrow Transplantation × Clear all
NCT01471444 2021-12-16

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

M.D. Anderson Cancer Center

Phase 3 Completed
256 enrolled 13 charts
MyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00822770 2020-10-14

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin

M.D. Anderson Cancer Center

Phase 1/2 Completed
47 enrolled 8 charts
MyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT00023530 2016-02-18

Blood and Marrow Transplant Clinical Research Network

National Heart, Lung, and Blood Institute (NHLBI)

Phase NA Completed
MyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hematologic Diseases, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡